BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Obelis Group - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Obelis Group
X-ORIGINAL-URL:https://www.obelis.net
X-WR-CALDESC:Events for Obelis Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260501T000000
DTEND;TZID=Europe/Brussels:20260501T235959
DTSTAMP:20260418T063517
CREATED:20260119T105105Z
LAST-MODIFIED:20260121T084723Z
UID:10000030-1777593600-1777679999@www.obelis.net
SUMMARY:Omnibus Act VIII – May 2026
DESCRIPTION:European Union – Omnibus Act VIII amends the Cosmetic Regulations\n\n\n\n✅1 May 2026: Products containing 3-(4′-methylbenzylidene)-camphor [INCI: 4-Methylbenzylidene Camphor] (CAS No 36861-47-9/38102-62-4) can no longer be made available on the market. \n\n\n\n✅1 May 2026: With no distinction between placing products on the market and making them available\, Omnibus Act VIII will apply. This means that\, from the application date\, non-compliant cosmetics can no longer be sold in the EU market and must be recalled beforehand. \n\n\n\nMeeting regulatory deadlines is essential to avoid market disruptions and product recalls\, and Obelis is here to support you every step of the way in ensuring timely compliance with Omnibus Act VIII requirements. \n\n\n\n\n\n\n\n\nNew amendment to EU Cosmetics Regulation: Retinol and other substances banned or restricted in cosmetics – COSlaw.eu – Guiding through EU Cosmetics Regulations: Winning with IVDR: Compliance Strategy\, Class C Pathways & NB Engagement
URL:https://www.obelis.net/events/omnibus-act-viii-may-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/271.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260505T090000
DTEND;TZID=Europe/Brussels:20260506T180000
DTSTAMP:20260418T063517
CREATED:20260311T141728Z
LAST-MODIFIED:20260311T143344Z
UID:10000041-1777971600-1778090400@www.obelis.net
SUMMARY:GITEX Future Health Africa
DESCRIPTION:Heading to GITEX Future Health Africa?As Africa’s leading platform for health innovation and policy\, GITEX Future Health Africa is where healthcare’s evolution meets the continent’s digital future. Obelis Group is more than excited to be a part of this transformative event in Morocco this May. \n\n\n\nIn an era where AI and deep tech are reimagining health systems\, Obelis stands ready to support your journey. We help MedTech and Digital Health innovators navigate complex regulatory landscapes. \n\n\n\nWhat you can expect when you meet us in Morocco: \n\n\n\n✅ Strategic Roadmaps: Expert advice on scaling your health innovations across African and international borders.✅ Tech-Forward Compliance: Clear guidance on regulatory requirements for AI-driven devices\, software as a medical device (SaMD)\, and emerging health tech.✅ Accelerated Market Entry: Practical support to streamline approvals\, ensuring your life-saving technology reaches providers and patients faster. \n\n\n\nDon’t leave your regulatory strategy to chance. Book a dedicated slot with our experts ahead of time and maximise your impact at GITEX Future Health Africa. \n\n\n\nLooking forward to connecting with you in Morocco on 5-6 May!
URL:https://www.obelis.net/events/gitex-future-health-africa/
CATEGORIES:Exhibitions
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/03/GITEX.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260506T113000
DTEND;TZID=Europe/Brussels:20260506T123000
DTSTAMP:20260418T063517
CREATED:20260414T131053Z
LAST-MODIFIED:20260414T131248Z
UID:10000045-1778067000-1778070600@www.obelis.net
SUMMARY:Winning with IVDR: Compliance Strategy\, Class C Pathways & NB Engagement
DESCRIPTION:The IVDR transition is reshaping how IVD manufacturers approach compliance\, evidence\, and certification. This session will guide you through the most critical elements of the journey\, from transition timelines and legacy provisions\, to EUDAMED and UDI requirements\, and what they mean in practice. \n\n\n\nWe will also dive into Class C classification and conformity assessment pathways\, highlight the most common clinical evidence gaps identified by Notified Bodies\, and share practical insights on how to work more effectively with Notified Bodies\, including smarter communication and selection strategies to support successful approvals.Join us to gain clarity\, reduce compliance risks\, and strengthen your IVDR strategy. Register now to secure your spot.
URL:https://www.obelis.net/events/winning-with-ivdr-compliance-strategy-class-c-pathways-nb-engagement/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/04/Event-Calendar-Featured-Image-29.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260507T100000
DTEND;TZID=Europe/Brussels:20260509T180000
DTSTAMP:20260418T063517
CREATED:20260319T105438Z
LAST-MODIFIED:20260413T141312Z
UID:10000043-1778148000-1778349600@www.obelis.net
SUMMARY:Beauty Istanbul 2026
DESCRIPTION:Keen on Beauty Care? Let’s meet at Beauty Istanbul\, one of the largest cosmetics exhibitions worldwide! Our Mission? Helping cosmetics brands seamlessly adapt to global compliance standards.Why Meet Us at Beauty Istanbul?✅ Expert insights on market access & compliance✅ Tailored strategies to accelerate approvals✅ Guidance on the latest regulatory updatesLet’s connect to discuss how we can support your regulatory needs! Schedule a meeting with us in advance\, and we’ll see you at our booth\, yours\, or wherever is convenient for you. \n\n\n\nObelis Booth: Hall 10/10A 430We look forward to meeting you at Beauty Istanbul!
URL:https://www.obelis.net/events/beauty-istanbul-2026/
CATEGORIES:Exhibitions
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/03/GITEX-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260526T000000
DTEND;TZID=Europe/Brussels:20260526T235959
DTSTAMP:20260418T063517
CREATED:20260127T081634Z
LAST-MODIFIED:20260127T082030Z
UID:10000037-1779753600-1779839999@www.obelis.net
SUMMARY:IVDR Class C Transitional Deadline – May 2026
DESCRIPTION:As the transition to the In Vitro Diagnostic Regulation (IVDR) continues\, we would like to remind you of the critical 2026 deadlines for legacy IVDs that are classified to Class C under IVDR. \n\n\n\nFor these devices\, the following milestones apply:  \n\n\n\n✅A written agreement between the manufacturer and the Notified Body must be signed by 26 September 2026. \n\n\n\n✅The manufacturer or their Authorised Representative must apply to a Notified Body for IVDR conformity assessment by 26 May 2026. \n\n\n\nObelis guides manufacturers through the IVDR transition\, including selecting and engaging with a Notified Body.
URL:https://www.obelis.net/events/ivdr-class-c-transitional-deadline-may-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/331.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260528T000000
DTEND;TZID=Europe/Brussels:20260528T235959
DTSTAMP:20260418T063517
CREATED:20260127T081040Z
LAST-MODIFIED:20260127T081211Z
UID:10000036-1779926400-1780012799@www.obelis.net
SUMMARY:EUDAMED Registration Becomes Mandatory – May 2026
DESCRIPTION:Regulatory Alert | EUDAMED becomes mandatory\n\n\n\nCommission Decision (EU) 2025/2371 confirms the full functionality of the first four EUDAMED modules. As a result\, economic operators must comply with mandatory registration requirements. \n\n\n\nMandatory modules from 28 May 2026: \n\n\n\n✅Market Surveillance \n\n\n\n✅Actors: registration of manufacturers\, authorised representatives\, importers \n\n\n\n✅UDI / Devices: device registration (excluding custom-made devices) \n\n\n\n✅Notified Bodies & Certificates \n\n\n\nA six-month transition period (until November 27\, 2026) applies only to devices placed on the market before May 28\, 2026. Devices placed on the market after this date must be registered before market access. \n\n\n\nObelis supports manufacturers at every step of EUDAMED compliance!
URL:https://www.obelis.net/events/eudamed-registration-becomes-mandatory-may-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/341.jpg
END:VEVENT
END:VCALENDAR